MARKET

TCRT

TCRT

Alaunos Therapeutics, Inc
NASDAQ
2.350
+0.190
+8.80%
After Hours: 2.372 +0.022 +0.93% 19:08 02/28 EST
OPEN
2.200
PREV CLOSE
2.160
HIGH
2.600
LOW
2.155
VOLUME
245.70K
TURNOVER
0
52 WEEK HIGH
10.50
52 WEEK LOW
0.6600
MARKET CAP
37.70M
P/E (TTM)
-1.0121
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at TCRT last week (0219-0223)?
Weekly Report · 2d ago
Alaunos Therapeutics Announces Executive Financial Leadership Changes
TipRanks · 6d ago
Alaunos Therapeutics Regains Nasdaq Listing Compliance
TipRanks · 02/20 21:28
Weekly Report: what happened at TCRT last week (0212-0216)?
Weekly Report · 02/19 12:19
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Cogent Biosciences (NASDAQ:COGT) shares rose 45.6% to $7.95 during Wednesday's pre-market session. Lineage Cell Therapeutics (AMEX:LCTX) stock rose 18.62% during the session. Alaunos Therapeutic stock increased by 17.39%. Losers Anitra stock declined by 67.8% and QuidelOrtho stock fell 39.35%.
Benzinga · 02/14 13:05
Weekly Report: what happened at TCRT last week (0205-0209)?
Weekly Report · 02/12 12:05
Weekly Report: what happened at TCRT last week (0129-0202)?
Weekly Report · 02/05 12:17
Why C.H. Robinson Shares Are Trading Lower By Over 12%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
C.H. Robinson Worldwide shares dipped 12.6% to $73.49 on Thursday. The company reported worse-than-expected fourth-quarter financial results. Minim, Inc. Shares climbed 57.3% in today's mid-day session. Etsy Inc. And Oragenics Inc. Were also among the stocks moving in Thursday's session.
Benzinga · 02/01 18:17
More
About TCRT
Alaunos Therapeutics, Inc. is a clinical-stage oncology-focused cell therapy company. It is engaged in developing adoptive TCR engineered T-cell therapies (TCR-T), designed to treat multiple solid tumor types in large cancer patient populations. It is leveraging its cancer mutation hotspot TCR library and its non-viral Sleeping Beauty genetic engineering technology to design and manufacture patient-specific cell therapies that target neoantigens arising from common tumor-related mutations in oncogenic genes, including KRAS, TP53 and EGFR. Its TCR library consists of ten TCRs targeting six solid tumor indications, such as non-small cell lung, colorectal, endometrial, pancreatic, ovarian and bile duct cancers. Using its human neoantigen T cell Receptor discovery engine, it analyzes thousands of single T cells simultaneously using bioinformatics and next generation sequencing. Its pipeline in cell therapy for oncology consists of Library TCR-T cell therapy and mbIL-15 TCR-T cell therapy.

Webull offers Alaunos Therapeutics Inc stock information, including NASDAQ: TCRT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TCRT stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading TCRT stock methods without spending real money on the virtual paper trading platform.